Roberta Cortivo

Roberta Cortivo

Auto-generated profile, based on publicly available information

Roberta Cortivo

Dept of Histology, Microbiology and Biomedical Technologies, University of Padova Viale G. Colombo 3, 35131 Padova, Italy

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
VVVincenzo Vindigni
Vincenzo Vindigni
RCRoberta Cortivo
Roberta Cortivo
LILaura Iacobellis
Laura Iacobellis
GAGiovanni Abatangelo
Giovanni Abatangelo
Barbara ZavanBarbara Zavan
Barbara Zavan
Tissue engineering is a multidisciplinary field focused on in vitro reconstruction of mammalian tissues. In order to allow a similar three-dimensional organization of in vitro cultured cells, biocompatible scaffolds are needed. This need has provided immense momentum for research on “smart scaffolds” for use in cell culture. One of the most promising materials for tissue engineering and regenerative medicine is a hyaluronan derivative: a benzyl ester of hyaluronan (HYAFF®). HYAFF® can be processed to obtain several types of devices such as tubes, membranes, non-woven fabrics, gauzes, and sponges. All these scaffolds are highly biocompatible. In the human body they do not elicit any adverse reactions and are resorbed by the host tissues. Human hepatocytes, dermal fibroblasts and keratinocytes, chondrocytes, Schwann cells, bone marrow derived mesenchymal stem cells and adipose tissue derived mesenchymal stem cells have been successfully cultured in these meshes. The same scaffolds, in tube meshes, has been applied for vascular tissue engineering that has emerged as a promising technology for the design of an ideal, responsive, living conduit with properties similar to that of native tissue.

11 November 2008 in Arthritis Research & Therapy
Verified
Journal Article
Open access
Paola BrunPaola Brun
Paola Brun
SDSally C Dickinson
Sally C Dickinson
Barbara ZavanBarbara Zavan
Barbara Zavan
RCRoberta Cortivo
Roberta Cortivo
AHAnthony P Hollander
Anthony P Hollander
GAGiovanni Abatangelo
Giovanni Abatangelo
Introduction: The present study established characteristics of tissue regrowth in patients suffering knee lesions treated with grafts of autologous chondrocytes grown on three-dimensional hyaluronic acid biomaterials. Methods: This multicentred study involved a second-look arthroscopy/biopsy, 5 to 33 months post implant (n = 63). Seven patients allowed a third-look biopsy, three of which were performed 18 months post implant. Characteristics of tissues were histologically and histochemically evaluated. The remaining bone stubs were evaluated for cartilage/bone integration. For data analysis, biopsies were further divided into those obtained from postoperative symptomatic patients (n = 41) or from asymptomatic patients (n = 22). Results: The percentage of hyaline regenerated tissues was significantly greater in biopsies obtained after, versus within, 18 months of implantation. Differences were also observed between symptomatic and asymptomatic patients: reparative tissues taken from symptomatic patients 18 months after grafting were mainly fibrocartilage or mixed (hyaline–fibrocartilage) tissue, while tissues taken from asymptomatic patients were hyaline cartilage in 83% of biopsies. In a small group of asymptomatic patients (n = 3), second-look and third-look biopsies taken 18 months after surgery confirmed maturation of the newly formed tissue over time. Cartilage maturation occurred from the inner regions of the graft, in contact with subchondral bone, towards the periphery of the implant. Conclusions: The study indicates that, in asymptomatic patients after chondrocyte implantation, regenerated tissue undergoes a process of maturation that in the majority of cases takes longer than 18 months for completion and leads to hyaline tissue and not fibrous cartilage. Persistence of symptoms might reflect the presence of a nonhyaline cartilage repair tissue.

1 July 2010
Verified
Journal Article
Closed access
Barbara ZavanBarbara Zavan
Barbara Zavan
VVVincenzo Vindigni
Vincenzo Vindigni
CGChiara Gardin
Chiara Gardin
DDDomenico D'Avella
Domenico D'Avella
APAlessandro Della Puppa
Alessandro Della Puppa
RCRoberta Cortivo
Roberta Cortivo

1 January 2009
Verified
Book Chapter
Closed access
PDF file
Barbara ZavanBarbara Zavan
Barbara Zavan
RCRoberta Cortivo
Roberta Cortivo
GAGiovanni Abatangelo
Giovanni Abatangelo

1 May 1998 in Journal of Biomedical Materials Research
Verified
Journal Article
Closed access
PDF file
VZValentina Zacchi
Valentina Zacchi
CSCarlo Soranzo
Carlo Soranzo
RCRoberta Cortivo
Roberta Cortivo
MRMarco Radice
Marco Radice
Paola BrunPaola Brun
Paola Brun
GAGiovanni Abatangelo
Giovanni Abatangelo

1 May 2006 in Journal of Reconstructive Microsurgery
Verified
Journal Article
Closed access
VVVincenzo Vindigni
Vincenzo Vindigni
SLSandro Lepidi
Sandro Lepidi
RCRoberta Cortivo
Roberta Cortivo
BZBarbara Zavan
Barbara Zavan
GAGiovanni Abatangelo
Giovanni Abatangelo
The aim of this presented study was to evaluate a prosthetic graft capable of performing adequately as a small diameter conduit (2 mm diameter), using an in vivo tissue engineering approach. The authors decided to reproduce and positively guide the remodelling process directly in vivo, using a 2 mm in diameter and 1 cm in length hyaluronic acid-based tubular scaffold (HYAFF-11) that functioned only as a temporary absorbable guide, similar to an in vivo “artery bioregeneration assist tube” (ABAT). This biomaterial was chosen for its documented capacity to promote adhesion and proliferation of endothelial and smooth muscle vascular cells. Its biodegradability and biocompatibility were also well-documented. Thirty male Wistar rats weighing 250 to 350 g were used. The aorta, from the renal arteries to the aortic trifurcation, was exposed and isolated. A segment of aorta (1 cm) was incised and a HYAFF 11™ tube was anastomosed, first proximally and then distally, in an end-to-end fashion with interrupted stitches of 10-0 nylon suture. No anticoagulants were used either before or after the operation. Histologic (hematoxylin-eosin and Weighert solution), immunohistochemical (antibodies to von Willebrand factor, CD34, vascular endothelial growth factor receptor-2 and to myosin light chain kinase) and ultra-structural analysis were used to evaluate the results at 5, 15, 30, 60, 120, and 180 days after surgery. Three novel findings stood out in evaluation of results: endothelialization of the tube luminal surface within 5 days; sequential regeneration of the other vascular components that led to complete vascular-wall regeneration after 15 days post surgery; and temporariness of the tube – biomaterial was entirely degraded after 4 months post implantation and, after that, a new artery remained to connect artery stumps. This study assessed the feasibility of creating a completely biodegradable vascular regeneration guide in vivo. The most important finding was the ability of the proposed vascular prostheses to sequentially orchestrate the vascular regeneration events required for very small artery reconstruction. Until now, this has been defined as the holy grail of vascular biology, given the great difficulty in obtaining in vivo significant long-term patency and acceptable wall mechanical strength.